A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD (RILISE)
A Pilot Study of Riluzole vs. Placebo in the Treatment of Children and Adolescents With Autism Spectrum Disorders
Sponsor: Holland Bloorview Kids Rehabilitation Hospital
Listed as NCT01661855, this PHASE2 trial focuses on Autism Spectrum Disorders and remains completed. Sponsored by Holland Bloorview Kids Rehabilitation Hospital, it has been updated 7 times since 2013, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
7 versions recorded-
Aug 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Aug 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Oct 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Oct 2021 [monthly]
Completed PHASE2
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Holland Bloorview Kids Rehabilitation Hospital
- McMaster University
- The Hospital for Sick Children
- The University of Western Ontario
- Unity Health Toronto
- University of Toronto
For direct contact, visit the study record on ClinicalTrials.gov .